These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Impact of Acetazolamide, a Carbonic Anhydrase Inhibitor, on the Development of Intestinal Polyps in Min Mice. Noma N; Fujii G; Miyamoto S; Komiya M; Nakanishi R; Shimura M; Tanuma SI; Mutoh M Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420165 [TBL] [Abstract][Full Text] [Related]
8. Sesamol suppresses cyclooxygenase-2 transcriptional activity in colon cancer cells and modifies intestinal polyp development in Apc (Min/+) mice. Shimizu S; Fujii G; Takahashi M; Nakanishi R; Komiya M; Shimura M; Noma N; Onuma W; Terasaki M; Yano T; Mutoh M J Clin Biochem Nutr; 2014 Mar; 54(2):95-101. PubMed ID: 24688218 [TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Rajamanickam S; Velmurugan B; Kaur M; Singh RP; Agarwal R Cancer Res; 2010 Mar; 70(6):2368-78. PubMed ID: 20215518 [TBL] [Abstract][Full Text] [Related]
10. Activation of NF-E2 p45-related factor-2 transcription and inhibition of intestinal tumor development by AHCC, a standardized extract of cultured Takahashi M; Fujii G; Hamoya T; Kurokawa Y; Matsuzawa Y; Miki K; Komiya M; Narita T; Mutoh M J Clin Biochem Nutr; 2019 Nov; 65(3):203-208. PubMed ID: 31777421 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of 5-aminosalicylic acid (5-ASA) for cancer chemoprevention: lack of efficacy against nascent adenomatous polyps in the Apc(Min) mouse. Ritland SR; Leighton JA; Hirsch RE; Morrow JD; Weaver AL; Gendler SJ Clin Cancer Res; 1999 Apr; 5(4):855-63. PubMed ID: 10213222 [TBL] [Abstract][Full Text] [Related]
13. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607 [TBL] [Abstract][Full Text] [Related]
14. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor. Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063 [TBL] [Abstract][Full Text] [Related]
15. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
16. Concurrent suppression of hyperlipidemia and intestinal polyp formation by NO-1886, increasing lipoprotein lipase activity in Min mice. Niho N; Mutoh M; Takahashi M; Tsutsumi K; Sugimura T; Wakabayashi K Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2970-4. PubMed ID: 15710887 [TBL] [Abstract][Full Text] [Related]
17. The orphan receptor TR3 suppresses intestinal tumorigenesis in mice by downregulating Wnt signalling. Chen HZ; Liu QF; Li L; Wang WJ; Yao LM; Yang M; Liu B; Chen W; Zhan YY; Zhang MQ; Cai JC; Zheng ZH; Lin SC; Li BA; Wu Q Gut; 2012 May; 61(5):714-24. PubMed ID: 21873734 [TBL] [Abstract][Full Text] [Related]
19. The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in Apc Ono J; Shime H; Takaki H; Takashima K; Funami K; Yoshida S; Takeda Y; Matsumoto M; Kasahara M; Seya T J Biomed Sci; 2017 Oct; 24(1):79. PubMed ID: 29041928 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]